Combination of stem cells and nerve guide conduit for the treatment of peripheral nerve injury: A meta‐analysis

Abstract

AbstractIntroduction/AimsMany small‐sized, single‐center preclinical studies have investigated the benefits of introducing stem cells into the interior of nerve conduit. The aims of this meta‐analysis are to review and contrast the effects of various types of stem cells in in vivo models used to reconstruct peripheral nerve injuries (PNIs) and to assess the reliability and stability of the available evidence.MethodsA systematic search was conducted using Cochrane Library, Embase, PubMed, and Web of Science to identify studies conducted from January 1, 2000, to September 21, 2022, and investigate stem cell therapy in peripheral nerve reconstruction animal models. Studies that met the relevant criteria were deemed eligible for this meta‐analysis.ResultsFifty‐five preclinical studies with a total of 1234 animals were incorporated. Stem cells demonstrated a positive impact on peripheral nerve regeneration at different follow‐up times in the forest plots of five outcome indicators: compound muscle action potential (CMAP) amplitude, latency, muscle mass ratio, nerve conduction velocity, and sciatic functional index (SFI). In most comparisons, stem cell groups showed substantial differences compared with the control groups. The superior performance of adipose‐derived stem cells (ADSCs) in terms of SFI, CMAP amplitude, and latency (p < .001) was identified.DiscussionThe findings consistently demonstrated a favorable outcome in the reconstruction process when utilizing different groups of stem cells, as opposed to control groups where stem cells were not employed.